NCT06977698
- Conditions
- Breast Cancer Invasive, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Nottingham university hospitals Nottingham, United Kingdom
Clinical trial condition
Breast Cancer Invasive
Explore clinical trials studying Breast Cancer Invasive. Study availability and eligibility vary by location and protocol.
43 public trials
21 recruiting studies
Breast Cancer Invasive trial results
NCT04891068
- Conditions
- Breast Cancer Invasive, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- University of Illinois Cancer Center Chicago, Illinois, United States
NCT05877859
- Conditions
- Breast Cancer Invasive, Breast Cancer Stage II, Breast Cancer Stage III, +8 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT06807502
- Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Invasive, Breast Cancer, Metastatic, +11 more
- Locations
-
- CMC Ambroise Paré Hartmann Neuilly-sur-Seine, France
NCT07505797
- Conditions
- Benign Breast Condition, Breast Cancer, Breast Cancer Female, +30 more
- Locations
-
- UC Davis Sacramento, California, United States
Recruiting
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT06268665
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Cancer Invasive, +53 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT05351424
- Conditions
- Breast Cancer Invasive, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Mount Sinai Medical Center Miami Beach, Florida, United States
- Columbia University Irving Medical Center New York, United States
NCT07188246
- Conditions
- Breast Cancer, Breast Cancer Invasive, Breast Cancer Stage II, +9 more
- Locations
-
- St. Joseph's Health Care London London, Ontario, Canada
- St. Joseph's Health Care London London, Ontario, Canada
NCT06958991
- Conditions
- Breast Cancer Invasive, Breast Cancer Surgery, Confocal Laser Endomicroscopy, +1 more
- Locations
-
- HFR Villars-sûr-glâne, Canton of Fribourg, Switzerland
Recruiting
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
NCT05910398
- Conditions
- Breast Cancer Invasive
- Locations
-
- Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai, China